Injective (INJ) is consolidating near a key monthly demand zone after a significant decline, attracting attention from long-term investors. Technical indicators like the RSI and MACD show early signs of improving buying momentum. Analyst projections suggest potential upside targets ranging from $16 to $53, contingent on sustained support and confirmed bullish patterns.
The Injective (INJ) token is showing signs of stabilization near a critical monthly demand zone. This area, identified as a high-timeframe order block, previously catalyzed a rally of nearly 4,500% in a past cycle, according to an analysis by Crypto Patel.
At the time of writing, INJ is trading at $3.06, with a market capitalization of approximately $306 million. Data from CoinMarketCap shows a 24-hour trading volume of around $40 million and a modest daily gain of 1.33%.
The analysis notes that INJ has declined by almost 95%, a scale typical of major crypto market resets. Investors are watching for confirmation signals like the establishment of higher weekly lows or a Change in State of Delivery to indicate sustained buyer accumulation.
Technical indicators show a gradual improvement in momentum despite the prevailing downtrend. The Relative Strength Index is at 46.92, while the MACD line has crossed above its signal line, resulting in a positive histogram reading of 0.037.
Potential long-term price targets are identified at $16, $35, and $53. These projections are conditional on the token maintaining current support levels and developing stronger bullish patterns in the market structure.
